The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: bioOasis Technologies

Monday Deal Review: September 3, 2012

Welcome to your Monday Biotech Deal Review for September 3, 2012.  A slow week was capped by today’s announcement that Valeant Pharmaceuticals International Inc. will acquire dermatology specialist Medicis Pharmaceuticals Corporation.  The deal, which pushes Valeant’s total 2012 acquisition spending to over $3.5 billion, continues Valeant CEO Michael Pearson’s strategy of “using M&A as a surrogate for R&D.” Read on to learn more.
Read more of this post

Follow

Get every new post delivered to your Inbox.

Join 130 other followers